Associated Papers
Niraparib for the treatment of metastatic ccRCC in a patient with CDK12 and RAD51C mutations: a case report.
Yue X et al.
Frontiers in Pharmacology, 2024
Homologous recombination-deficient mutation cluster in tumor suppressor RAD51C identified by comprehensive analysis of cancer variants.
Prakash R et al.
Proceedings of the National Academy of Sciences of the United States of America, 2022
36099300 (PubMed )
Supplement: pnas.2202727119.sapp.pdf
Select a paper to view details